Viewing Study NCT07256392


Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2025-12-25 @ 7:53 PM
Study NCT ID: NCT07256392
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Sponsor: Celldex Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module